Our Team

The co-founder Rainer Lipp, M.D., who is board certified specialist in internal medicine, haematology and oncology and also the chief medical officer, is in charge of executive management.

After studying medicine at the Medical University of Lübeck, Dr Lipp completed his specialist training at the Centre for Pulmonary Diseases and Thoracic Surgery at the Großhansdorf Hospital, the Westphalian Wilhelm University and the University Hospital Hamburg-Eppendorf.
Following a stopover at Aventis Pharma Germany as Medical Director of Oncology, Dr Lipp founded a research- and consulting company in Hamburg, in 2003.
This company was one of the first external study centres for a large oncological practise specialising in pivotal international studies, so Dr. Lipp has served as a Principle Investigator in more than 80 licensing-relevant studies and as Head of Clinical Trials in accordance with the AMG, in more than ten studies. Most recently, Dr Lipp was responsible for the entire project management of the GermanOncology projects and the registry in the field of oncological care research.

In addition to clinical research, Dr Lipp also specialised in healthcare research and cost analyses of oncological therapy- and analysis procedures, as well as in advising pharmaceutical companies, clinics and statutory health insurance physicians. Here he placed particular emphasis on the development of cross-sectoral collaboration models and the analysis of the various forms of care in the German healthcare system and the resulting reimbursement processes.

Dr Lipp is a member of numerous oncological societies and various national and international expert boards. Since 2004, Dr Lipp has been part of the German Health Insurance (DKV/Ergo Group) expert´s network “Best Care”, in which experts will focus on oncological second opinions for national and international patients.
Dr Lipp is a co-author of many international publications and is a sought-after speaker and moderator at symposia and workshops focusing on forms of care and reimbursement processes.

Since 2015, Peter Brecht is Senior Business Consultant and authorised signatory at GermanOncology.

A graduate in business administration, he has had a unique career in the pharmaceutical industry for more than 30 years. He gained his wealth of experience in leading positions in management, marketing and sales at large companies such as Knoll AG, Pharmacia, Bristol Myers Squibb, Chiron, Nycomed, Nestlé, MerckSerono and Novo Nordisk.

In the constantly changing environment of the pharmaceutical industry, Mr Brecht has successfully implemented his sound business management knowledge in eight mergers in change processes. In his function as Director of Sales in several companies, he has developed and repeatedly successfully applied new business models, both nationally and internationally, to address customers.

The rebuilding of sales structures on a national and international level and motivation-driven management coaching were the focal points and success factors of his many years of activity. Internships in various specialist departments in clinics in Germany and other European countries (including Sweden and France), as well as in numerous practices in Germany, provided him with detailed insight into various cross-sectoral treatment pathways and optimised his skills in needs-oriented benefit reasoning.
Within GermanOncology, Peter Brecht works with a focus on internal and external communication with the oncological network, project acquisition, support and implementation, as well as the development of new business models within the framework of Real World Data and Patient Report-Outcomes (PRO).